2023 Second Quarter Financial and Corporate Update

2023 Second Quarter. Financial and Corporate Update. AUGUST 1, 2023. Page 2. 2 xx. Forward-Looking Statements. Except for the historical information set ...

BioNTech Announces Second Quarter 2023 Financial Results and ...

BioNTech Announces Second Quarter 2023 Financial Results and Corporate Update ... MAINZ, Germany, August 7, 2023 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “ ...

Scholar Rock Reports Second Quarter 2023 Financial Results and ...

June 30, 2023 ; Assets. Cash, cash equivalents and marketable securities ; Cash, cash equivalents and marketable securities. $. 248,734 ; Other current assets.

Incyte Reports 2023 Second Quarter Financial Results and Provides ...

Incyte (Nasdaq:INCY) today reports 2023 second quarter financial results, and provides a status update on the Company's clinical development portfolio.

Moderna Reports Second Quarter 2023 Financial Results and ...

Second quarter 2023 revenues of $0.3 billion; net loss of $1.4 billion and loss per share of $3.62 Company expecting 2023 COVID-19 vaccine ...

Avadel Pharmaceuticals Provides Corporate Update and Reports ...

Recognized $41.5 million in net product revenue for the second quarter 2024 compared to $1.5 million in the same period in 2023.

PTC Therapeutics Provides Corporate Update and Reports Second ...

Emflaza net product revenues were $47.3 million for the second quarter of 2024, compared to $65.7 million for the second quarter of 2023. These ...

Corcept Therapeutics Announces Second Quarter Financial Results ...

Second quarter operating expenses were $128.2 million , compared to $88.1 million in the second quarter of 2023, due to increased spending on ...

IGM Biosciences Announces Second Quarter 2024 Financial ...

IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update ... second quarter of 2023. General and ...

FMC Corporation announces second quarter earnings at higher end ...

Share: · Updates revenue outlook to range of $4.30 billion to $4.50 billion, reflecting a 2 percent decline at the midpoint versus 2023 · Reduces adjusted EBITDA ...

Second quarter 2023 financial results - Sanofi

Second quarter 2023 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A ...

Revvity Announces Financial Results for the Second Quarter of 2023

Second quarter 2023 adjusted operating profit margin was 22.9% as a percentage of adjusted revenue, as compared to 43.0% in the same period a year ago. Updates ...

Boeing Reports Second Quarter Results

Total company backlog at quarter end was $516 billion. Segment Results. Commercial Airplanes ...

Ultragenyx Reports Second Quarter 2024 Financial Results and ...

Ultragenyx Reports Second Quarter 2024 Financial Results and Corporate Update ... quarter of 2023 of $160 million, or $2.25 per share basic and diluted.

Pyxis Oncology Provides Corporate Update and Reports Financial ...

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 ... quarter ended June 30, 2023. The period-over-period ...

Revance Reports Second Quarter 2023 Financial Results, Provides ...

At-the-market (ATM) program. During the second quarter, the company issued 3.2 million shares of common stock pursuant to the company's ATM ...

Exelixis Announces Second Quarter 2023 Financial Results and ...

Total revenues for the quarter ended June 30, 2023 included net product revenues of $409.6 million , as compared to $347.0 million for the ...

Vertex Reports Second Quarter 2023 Financial Results

Net product revenue in the second quarter of 2023 increased 7% to $1.51 billion in the U.S. and increased 26% to $985 million outside the U.S. , ...

Bristol Myers Squibb Reports Second Quarter Financial Results for ...

Results Underscore Continued Progress on Commercial Execution, Driving the Growth Portfolio and Pipeline Advancement Second Quarter Revenues ...

Aclaris Therapeutics Reports Second Quarter 2024 Financial ...

Aclaris Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update ... $29.6 million for the second quarter of 2023. Total ...